This revised pathway includes expanded use of FIT, aligning to guidance from the British Society of Gastroenterology (BSG) and Association of Coloproctology of Great Britain & Ireland (ACPGBI), which is supported by NHSE and accredited by NICE. It is also underpinned by compelling evidence to support the use of FIT in conjunction with relevant blood tests, history and clinical examination to determine the appropriate referral or management pathway, improving the detection of cancers and improve patient experience.
Click here to access ‘The Cheshire and Merseyside pathway for Urgent Suspected LGI Cancer, incorporating FIT’ page.
